
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
05/09/2025 | Q1 | -- | $32.3M | -$20.73 | -- | -- |
03/07/2025 | Q4 | -- | $27.5M | -$44.50 | -- | -- |
11/08/2024 | Q3 | -- | $28.6M | -$305.00 | -- | -- |
08/08/2024 | Q2 | -- | $34.4M | -$105.38 | -$137.24 | $31.86 |
05/15/2024 | Q1 | $32.9M | $34M | -$125.46 | -$122.53 | -$2.93 |
03/27/2024 | Q4 | $30.2M | $29.5M | -$177.55 | -$117.63 | -$59.92 |
11/14/2023 | Q3 | $30.2M | $28.1M | -$230.36 | -$169.09 | -$61.27 |
08/10/2023 | Q2 | $29.2M | $32.8M | -$257.32 | -$98.02 | -$159.29 |
05/02/2023 | Q1 | $26.1M | $28.9M | -$137.23 | -$39.21 | -$98.02 |
03/31/2023 | Q4 | $25.2M | $25.9M | -$95.57 | -$39.21 | -$56.36 |
11/14/2022 | Q3 | $25.5M | $24.9M | -$122.53 | -$31.86 | -$90.67 |
08/09/2022 | Q2 | -- | $26.4M | -$24.51 | -- | -- |
05/11/2022 | Q1 | -- | $24.8M | -$29.41 | -- | -- |
03/16/2022 | Q4 | -- | $25.1M | -$46.56 | -- | -- |
11/09/2021 | Q3 | -- | $24.2M | -$34.31 | -- | -- |
08/09/2021 | Q2 | -- | $22.7M | -$68.62 | -- | -- |
05/10/2021 | Q1 | -- | $18.9M | -$127.62 | -- | -- |
03/16/2021 | Q4 | -- | $17.8M | -$139.22 | -- | -- |
11/09/2020 | Q3 | -- | $17.3M | -$159.29 | -- | -- |
08/10/2020 | Q2 | -- | $16.5M | -$134.78 | -- | -- |
05/11/2020 | Q1 | -- | $25.5M | -$106.74 | -- | -- |
03/16/2020 | Q4 | -- | $26.6M | -$183.31 | -- | -- |
11/08/2019 | Q3 | -- | $29.2M | -$25.52 | -- | -- |
08/08/2019 | Q2 | -- | $36.9M | $742.53 | -- | -- |
05/13/2019 | Q1 | -- | $47.3M | $4,385.54 | -- | -- |
03/18/2019 | Q4 | -- | $50M | -$76.57 | -- | -- |
11/13/2018 | Q3 | -- | $47.6M | -$69.61 | -- | -- |
08/09/2018 | Q2 | -- | $51.5M | -$27.84 | -- | -- |
05/10/2018 | Q1 | -- | $48.3M | -$48.73 | -- | -- |
12/31/2017 | Q4 | -- | $52.4M | $424.63 | -- | -- |
11/09/2017 | Q3 | -- | $55.4M | $870.15 | -- | -- |
08/09/2017 | Q2 | -- | $61.3M | $807.50 | -- | -- |
05/10/2017 | Q1 | -- | $66.9M | $1,608.03 | -- | -- |
03/21/2017 | Q4 | -- | $64.6M | -$6.96 | -- | -- |
11/09/2016 | Q3 | -- | $64.3M | $69.61 | -- | -- |
08/09/2016 | Q2 | -- | $68.4M | $6.96 | -- | -- |
05/09/2016 | Q1 | -- | $68.6M | $194.91 | -- | -- |
04/04/2016 | Q4 | -- | $70M | $83.53 | -- | -- |
12/07/2015 | Q3 | -- | $68.5M | $34.81 | -- | -- |
Creative Media & Community Trust reported $32.3M worth of top line sales in its most recent quarter.
Creative Media & Community Trust announced earnings per share of -$20.73 which represents a miss of analyst forecast a -- per share.
Creative Media & Community Trust reported $13.5M that represents $23.56 per share over the last quarter.
Creative Media & Community Trust's earnings are forecast to decrease from -$430.25 per share to -- per share next year representing a decrease of -25.74%.
Creative Media & Community Trust's next earnings date is August 8, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.